Hemophagocytic lymphohistiocytosis in inflammatory bowel disease: a nationwide analysis

Keyphrases

• Inflammatory Bowel Disease 100%
• Hemophagocytic Lymphohistiocytosis 100%
• Subnational Analysis 100%
• Hospitalization 11%
• Length of Hospital Stay 11%
• In-hospital Mortality 11%
• Ulcerative Colitis 11%
• Crohn's Disease 11%
• Demographic Characteristics 5%
• Life-threatening 5%
• Comorbidity 5%
• Liver Disease 5%
• Immunosuppressive Therapy 5%
• Illness 5%
• Malignancy 5%
• Age at Diagnosis 5%
• Population-based Study 5%
• High Prevalence 5%
• Viral Infection 5%
• Diagnosis Treatment 5%
• Lymphoma 5%
• International Classification of Diseases 5%
• Autoimmune Disease 5%
• Early Recognition 5%
• Early Diagnosis 5%
• Asian Pacific Islander 5%
• Related Conditions 5%
• Aides 5%
• Cytomegalovirus Infection 5%
• Crohn's Colitis 5%
• Immune Dysregulation 5%
• Discharge Information 5%
• Tobacco Abuse 5%
• Aggressive Treatment 5%
• Patient Discharge 5%
• Median Income 5%
• Hypothyroidism 5%
• National Inpatient Sample 5%
• International Classification of Diseases-10 5%

Medicine and Dentistry

• Hemophagocytic Syndrome 100%
• Inflammatory Bowel Disease 100%
• Patient with Inflammatory Bowel Disease 27%
• Prevalence 16%
• Ulcerative Colitis 16%
• Crohn's Disease 16%
• International Classification of Diseases 11%
• Hospital Mortality 11%
• Diseases 11%
• Infection 5%
• Cancer 5%
• Immunosuppressive Treatment 5%
• Autoimmune Disease 5%
• Early Diagnosis 5%
• Tobacco Dependence 5%
• Virus Infection 5%
• Asian Pacific Islanders 5%
• Household 5%
• Cytomegalovirus Infection 5%
• Hypothyroidism 5%
• Immune Dysregulation 5%
• Comorbidity 5%
• National Inpatient Sample 5%
• Liver Disease 5%
• Primary Outcome 5%

Immunology and Microbiology

• Inflammatory Bowel Disease 100%
• Hemophagocytic Lymphohistiocytosis 100%
• Prevalence 16%
• Crohn's Disease 16%
• Ulcerative Colitis 16%
• International Classification of Diseases 11%
• Hospital Mortality 11%
• Viral Disease 5%
• Autoimmune Disease 5%
• Immune Dysregulation 5%
• Immunosuppressive Therapy 5%
• Cytomegalovirus Infection 5%
• Comorbidity 5%
• Infection 5%